Colon and colorectal cancers are among the most commonly diagnosed cancers in both men and women in the United States. A recent study released by the Journal of the National Cancer Institute shows these cancers are especially on the rise in millennials and GenX. The study showed the risk for these cancers increasing by around 3 percent each year.
The study also concluded that adults born in 1990 have a two-fold higher risk of being diagnosed with colon cancer compared to adults born around 1950. Furthermore, the risk of rectal cancer is four times higher in the younger generation.
Ovarian cancer is the most lethal gynecologic malignancy. While there are treatment options, the survival rate of women with epithelial ovarian cancer has changed little in the last 30 years.
Now, a National Institute of Health (NIH) grant awarded to University of Minnesota experts will aid a study for a new immunotherapy that could potentially treat the deadly cancer. The project will be led by Bruce Walcheck, Ph.D., professor in the University of Minnesota Veterinary and Biomedical Services Department at the College of Veterinary Medicine, Jimmy Wu, Ph.D. associate professor in the University of Minnesota Veterinary and Biomedical Sciences Department at the College of Veterinary Medicine, and Dan Kaufman, M.D., Ph.D., director of the cell therapy program at the University of California- San Diego.